Insiders · MCRB

David Arkowitz

Chief Financial Officer at Seres Therapeutics, Inc. (MCRB)

David Arkowitz has filed 18 insider reports with the SEC since March 2021, as director at iBio, Inc. (IBIO), director at Kineta, Inc./de (KA) and chief Financial Officer at Seres Therapeutics, Inc. (MCRB) and at 3 more companies. David Arkowitz made no open-market purchases or sales in the last 12 months. The latest filing, on November 24, 2025, reports grant or award at iBio, Inc. (IBIO).

Filings
18
Companies
6
Bought on market
$50K
Sold on market
$25.9K

Companies where David Arkowitz is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
iBio, Inc. logo
IBIO
iBio, Inc.
Directorsince November 202418,382$50K$2.72$0.801-71%Nov 24, 2025
Kineta, Inc./de logo
KA
Kineta, Inc./de
DirectorSep 5, 2024
Seres Therapeutics, Inc. logo
MCRB
Seres Therapeutics, Inc.
Chief Financial Officer182,442$9,743$1.33Feb 17, 2024
Kineta, Inc./de logo
YMTX
Kineta, Inc./de
DirectorApr 14, 2023
F-star Therapeutics, Inc. logo
FSTX
F-star Therapeutics, Inc.
Director0Mar 9, 2023
Flexion Therapeutics Inc logo
FLXN
Flexion Therapeutics Inc
Officer220,719$16.1K$23.4227May 12, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with David Arkowitz.

Compare David Arkowitz with

Other insiders at the same companies

Questions about David Arkowitz

What is David Arkowitz's role at Seres Therapeutics, Inc.?
David Arkowitz reports to the SEC as chief Financial Officer at Seres Therapeutics, Inc. (MCRB), according to the latest filing on February 17, 2024. David Arkowitz has also filed as director at iBio, Inc. (IBIO), director at Kineta, Inc./de (KA), director at Kineta, Inc./de (YMTX) and director at F-star Therapeutics, Inc. (FSTX).
How many shares does David Arkowitz own?
After the latest filing that states it, David Arkowitz directly owned 18,382 shares of iBio, Inc. (IBIO), 182,442 shares of Seres Therapeutics, Inc. (MCRB) and 220,719 shares of Flexion Therapeutics Inc (FLXN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David Arkowitz bought or sold stock recently?
The most recent open-market purchase was on January 10, 2025: bought 18,382 shares of iBio, Inc. (IBIO) for $50K at an average of $2.72. The most recent open-market sale was on February 16, 2024: sold 3,939 shares of Seres Therapeutics, Inc. (MCRB) for $4,254 at an average of $1.08.
How do I get alerts when David Arkowitz files?
Follow David Arkowitz on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Arkowitz (SEC CIK 0001296999). Totals count each trade once, skipping amendments whose original is on file, from Mar 3, 2021 on. View on SEC EDGAR · Get this as JSON